Another study in patients with stage III non-small-cell lung cancer showed that sequential anti-PD-L1 therapy after chemoradiotherapy was associated with better OS than that of chemoradiotherapy alone [47,51]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.